Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer
Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer
Pancreatic cancer is one of the most lethal tumors. The aim of this study is to provide an effective therapeutic discovery platform for pancreatic cancer by establishing and characterizing patient-derived organoids (PDOs).